{"id":377,"date":"2012-12-09T22:30:42","date_gmt":"2012-12-09T13:30:42","guid":{"rendered":"http:\/\/www.pharm.okayama-u.ac.jp\/lab\/meneki\/?page_id=377"},"modified":"2021-05-17T14:51:51","modified_gmt":"2021-05-17T05:51:51","slug":"papers_in_japanese","status":"publish","type":"page","link":"https:\/\/www.pharm.okayama-u.ac.jp\/lab\/bunsei\/publications\/seitai-2018\/papers_in_japanese\/","title":{"rendered":"\u548c\u6587"},"content":{"rendered":"

\u8ad6\u6587\u30ea\u30b9\u30c8\uff08\u548c\u6587\uff09<\/h2>\n

\u548c\u6587\u7dcf\u8aac<\/h3>\n

\u5275\u85ac\u306e\u6a19\u7684\u3068\u3057\u3066\u306e\u30de\u30b9\u30c8\u7d30\u80de\u3000\u7530\u4e2d\u3000\u667a\u4e4b\u3000MEDCHEM NEWS\u300024 (1), 33-38, 2014<\/p>\n

\u6a39\u72b6\u7d30\u80de\u306b\u304a\u3051\u308b\u7d30\u80de\u8868\u9762MHC-II\u5206\u5b50\u306e\u767a\u73fe\u5236\u5fa1\u6a5f\u69cb\u3000\u53e4\u7530\u3000\u548c\u5e78\u3000\u751f\u5316\u5b6686(1), 72-76, 2014<\/p>\n

\u30d2\u30b9\u30bf\u30df\u30f3\u3068\u30a2\u30ca\u30d5\u30a3\u30e9\u30ad\u30b7\u30fc\u3000\u7530\u4e2d\u3000\u667a\u4e4b\u3001\u53e4\u7530\u3000\u548c\u5e78\u3000\u30a2\u30ec\u30eb\u30ae\u30fc\u30fb\u514d\u75ab 20 (8), 50-54, 2013<\/p>\n

\u30de\u30b9\u30c8\u7d30\u80de\u7814\u7a76\u306e\u65b0\u305f\u306a\u5c55\u958b\u3000\u7530\u4e2d\u3000\u667a\u4e4b\u3001\u897f\u7530\u3000\u572d\u543e\u3000\u85ac\u5b66\u96d1\u8a8c 131 (1), 59-61, 2011<\/p>\n

\u76ae\u819a\u578b\u30de\u30b9\u30c8\u7d30\u80de\u30e2\u30c7\u30eb\u306e\u78ba\u7acb\u3068\u305d\u306e\u89e3\u6790\u3000\u7530\u4e2d\u3000\u667a\u4e4b\u3000\u85ac\u5b66\u96d1\u8a8c 131 (1), 63-71, 2011\uff08\u85ac\u5b66\u96d1\u8a8c\u306fJ-STAGE<\/a>\u304b\u3089\u95b2\u89a7\u53ef\u80fd\u3067\u3059\uff09<\/p>\n

\u30de\u30b9\u30c8\u7d30\u80de\u306e\u5206\u5316\u306b\u4f34\u3046\u6a5f\u80fd\u5236\u5fa1\uff08\u65e5\u672c\u751f\u5316\u5b66\u4f1a\u5968\u52b1\u8cde\u53d7\u8cde\uff09\u3000\u7530\u4e2d\u3000\u667a\u4e4b\u3000\u751f\u5316\u5b66 82 (11), 1021-1031, 2010\uff08\u751f\u5316\u5b66\u306f\u65e5\u672c\u751f\u5316\u5b66\u4f1a\u300c\u751f\u5316\u5b66\u300d\u8a8cHP<\/a>\u304b\u3089\u95b2\u89a7\u53ef\u80fd\u3067\u3059\uff09<\/p>\n

\u30de\u30b9\u30c8\u7d30\u80de\u306e\u6210\u719f\u3068\u30d2\u30a2\u30eb\u30ed\u30f3\u9178\u3000\u7530\u4e2d\u3000\u667a\u4e4b\u3000\u8868\u9762\u300045\u5dfb\u3001312-321, 2007<\/p>\n

IgE\u3092\u4ecb\u3059\u308b\u30de\u30b9\u30c8\u7d30\u80de\u6d3b\u6027\u5316\u306e\u591a\u69d8\u6027\u3000\u7279\u96c6\u300c\u30de\u30b9\u30c8\u7d30\u80de\u306e\u6d3b\u6027\u5316\u3092\u3081\u3050\u3063\u3066\u300d\u3000\u7530\u4e2d\u3000\u667a\u4e4b\u3000\u81e8\u5e8a\u514d\u75ab\u30fb\u30a2\u30ec\u30eb\u30ae\u30fc\u79d1\u300047\u5dfb\u3001421-426, 2007<\/p>\n

\u30de\u30b9\u30c8\u7d30\u80de\u306b\u304a\u3051\u308bIgE\u3092\u4ecb\u3057\u305f\u30d2\u30b9\u30bf\u30df\u30f3\u5408\u6210\u306e\u8a98\u5c0e\u6a5f\u69cb\u3000\u7279\u96c6\u300c\u30a2\u30ec\u30eb\u30ae\u30fc\u6027\u708e\u75c7\u53cd\u5fdc\u306b\u304a\u3051\u308b\u30d2\u30b9\u30bf\u30df\u30f3\u306e\u5f79\u5272\u3068\u6297\u30d2\u30b9\u30bf\u30df\u30f3\u85ac\u300d \u3000\u7530\u4e2d\u3000\u667a\u4e4b\u3000\u30a2\u30ec\u30eb\u30ae\u30fc\u79d1\u300121\u5dfb\u3001438-444, 2007<\/p>\n

\u5358\u91cf\u4f53IgE\u306b\u3088\u308b\u30de\u30b9\u30c8\u7d30\u80de\u306e\u6d3b\u6027\u5316\u3000\u7279\u96c6\u300c\u30a2\u30ec\u30eb\u30ae\u30fc\u75be\u60a3\u306b\u304a\u3051\u308b\u30de\u30b9\u30c8\u7d30\u80de\u306e\u4f4d\u7f6e\u3065\u3051\u300d\u3000\u7530\u4e2d\u3000\u667a\u4e4b\u3000\u30a2\u30ec\u30eb\u30ae\u30fc\u30fb\u514d\u75ab\u300113\u5dfb\u300150-56, 2006<\/p>\n

\u30d2\u30b9\u30bf\u30df\u30f3\u751f\u5408\u6210\u3092\u4ecb\u3057\u3066\u767a\u73fe\u3059\u308b\u751f\u7406\u6a5f\u80fd\u306e\u89e3\u6790<\/a>\uff08\u65e5\u672c\u85ac\u5b66\u4f1a\u5968\u52b1\u8cde\u53d7\u8cde\u8a18\u5ff5\u7dcf\u8aac\uff09\u3000\u7530\u4e2d\u3000\u667a\u4e4b\u3000\u85ac\u5b66\u96d1\u8a8c 123, 547-559, 2003<\/p>\n

\u30d2\u30b9\u30bf\u30df\u30f3\u751f\u5408\u6210\u306e\u5206\u5b50\u6a5f\u69cb\u3000\u7530\u4e2d\u3000\u667a\u4e4b\u3001\u5e02\u5ddd\u3000\u539a\u3000\u300c\u30d2\u30b9\u30bf\u30df\u30f3\u7814\u7a76\u306e\u6700\u8fd1\u306e\u9032\u6b69\u300d\u5225\u518a\u30fb\u533b\u5b66\u306e\u3042\u3086\u307f\uff08\u533b\u6b6f\u85ac\u51fa\u7248\uff09, 2000<\/p>\n

SRP \u975e\u4f9d\u5b58\u7684\u306a\u5c0f\u80de\u4f53\u3078\u306e\u30bf\u30f3\u30d1\u30af\u8cea\u8f38\u9001\u3000\u7530\u4e2d\u3000\u667a\u4e4b\u3000\u751f\u5316\u5b66 72 (2), 121-125, 2000<\/p>\n

\u30d2\u30b9\u30c1\u30b8\u30f3\u8131\u70ad\u9178\u9175\u7d20\u306e\u5206\u5b50\u751f\u7269\u5b66\u3000\u5e02\u5ddd\u3000\u539a\u3001\u7530\u4e2d\u3000\u667a\u4e4b\u3000\u533b\u5b66\u306e\u3042\u3086\u307f 188 (3), 163-167, 1999<\/p>\n

\u96d1\u8a8c\u8a18\u4e8b<\/h3>\n

\u8aa0\u5b9f\u306a\u7814\u7a76\u6d3b\u52d5\u306e\u305f\u3081\u306b(Part 1)\u3000\u7530\u4e2d\u3000\u667a\u4e4b\u3000\u30d5\u30a1\u30eb\u30de\u30b7\u30a2 52(2), 131-135, 2016
\n\u8aa0\u5b9f\u306a\u7814\u7a76\u6d3b\u52d5\u306e\u305f\u3081\u306b(Part 2)\u3000\u7530\u4e2d\u3000\u667a\u4e4b\u3000\u30d5\u30a1\u30eb\u30de\u30b7\u30a2 52(4), 317-321, 2016
\n\uff08J-STAGE\u30ea\u30f3\u30af\uff1aPart 1<\/a>, Part2<\/a>\uff09<\/p>\n

\u7c98\u819c\u95a2\u9023\u30a4\u30f3\u30d0\u30ea\u30a2\u30f3\u30c8T\u7d30\u80de\u306f\u7d30\u83cc\u7531\u6765\u30d3\u30bf\u30df\u30f3\u4ee3\u8b1d\u7269\u3092\u8a8d\u8b58\u3059\u308b\u3000\u53e4\u7530\u3000\u548c\u5e78\u3000\u30d5\u30a1\u30eb\u30de\u30b7\u30a2 49(8), 801, 2013<\/p>\n

\u7d44\u7e54\u74b0\u5883\u306b\u304a\u3051\u308b\u30de\u30b9\u30c8\u7d30\u80de\u306e\u65b0\u305f\u306a\u6a5f\u80fd\u3000\u7530\u4e2d\u3000\u667a\u4e4b\u3000\u65e5\u85ac\u7406\u8a8c 138, 301<\/p>\n

\u7db2\u7f85\u7684\u30b2\u30ce\u30e0\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u306b\u3088\u308b\u65b0\u305f\u306a\u85ac\u7269\u306e\u6a19\u7684\u63a2\u7d22\u6cd5\u306e\u958b\u767a\uff08\u300c\u6ce8\u76ee\u306e\u8ad6\u6587\u300d\uff09\u3000\u7530\u4e2d\u3000\u667a\u4e4b\u3000\u5316\u5b66 59, 60-61, 2004<\/p>\n

\u65b0\u305f\u306a\u6297\u30a2\u30ec\u30eb\u30ae\u30fc\u85ac\u306e\u6a19\u7684\uff1f\u30d2\u30b9\u30bf\u30df\u30f3 H4 \u53d7\u5bb9\u4f53\u306e\u767a\u898b\u3000\u7530\u4e2d\u3000\u667a\u4e4b\u3000\u30d5\u30a1\u30eb\u30de\u30b7\u30a2 38 (1), 64-65, 2002<\/p>\n","protected":false},"excerpt":{"rendered":"

\u8ad6\u6587\u30ea\u30b9\u30c8\uff08\u548c\u6587\uff09 \u548c\u6587\u7dcf\u8aac \u5275\u85ac\u306e\u6a19\u7684\u3068\u3057\u3066\u306e\u30de\u30b9\u30c8\u7d30\u80de\u3000\u7530\u4e2d\u3000\u667a\u4e4b\u3000MEDCHEM NEWS\u300024 (1), 33-38, 2014 \u6a39\u72b6\u7d30\u80de\u306b\u304a\u3051\u308b\u7d30\u80de\u8868\u9762MHC-II\u5206\u5b50\u306e\u767a\u73fe\u5236\u5fa1\u6a5f\u69cb\u3000\u53e4\u7530\u3000\u548c\u5e78\u3000\u751f\u5316\u5b6686(1 […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":864,"menu_order":3,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/www.pharm.okayama-u.ac.jp\/lab\/bunsei\/wp-json\/wp\/v2\/pages\/377"}],"collection":[{"href":"https:\/\/www.pharm.okayama-u.ac.jp\/lab\/bunsei\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.pharm.okayama-u.ac.jp\/lab\/bunsei\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharm.okayama-u.ac.jp\/lab\/bunsei\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharm.okayama-u.ac.jp\/lab\/bunsei\/wp-json\/wp\/v2\/comments?post=377"}],"version-history":[{"count":20,"href":"https:\/\/www.pharm.okayama-u.ac.jp\/lab\/bunsei\/wp-json\/wp\/v2\/pages\/377\/revisions"}],"predecessor-version":[{"id":890,"href":"https:\/\/www.pharm.okayama-u.ac.jp\/lab\/bunsei\/wp-json\/wp\/v2\/pages\/377\/revisions\/890"}],"up":[{"embeddable":true,"href":"https:\/\/www.pharm.okayama-u.ac.jp\/lab\/bunsei\/wp-json\/wp\/v2\/pages\/864"}],"wp:attachment":[{"href":"https:\/\/www.pharm.okayama-u.ac.jp\/lab\/bunsei\/wp-json\/wp\/v2\/media?parent=377"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}